[1]高佳敏,王 涛,朱云峰,等.尿酸/高密度脂蛋白胆固醇比值对2型糖尿病合并非酒精性脂肪性肝病的预测价值[J].陕西医学杂志,2025,54(3):323-327.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.007]
　GAO Jiamin,WANG Tao,ZHU Yunfeng,et al.Value of UHR in predicting type 2 diabetes mellitus combined with NAFLD[J].,2025,54(3):323-327.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.007]
点击复制

尿酸/高密度脂蛋白胆固醇比值对2型糖尿病合并非酒精性脂肪性肝病的预测价值
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年3期
页码:
323-327
栏目:
临床研究
出版日期:
2025-03-05

文章信息/Info

Title:
Value of UHR in predicting type 2 diabetes mellitus combined with NAFLD
作者:
高佳敏1; 王 涛2; 朱云峰2; 付瑞瑞1; 洪 彬1; 翁孝刚2
(1.新乡医学院第三附属医院内分泌科,河南 新乡453003; 2.新乡医学院第一附属医院内分泌科,河南 新乡 453100)
Author(s):
GAO Jiamin1; WANG Tao2; ZHU Yunfeng2; FU Ruirui1; HONG Bin1; WENG Xiaogang2
(1.Department of Endocrinology,the Third Affiliated Hospital of Xinxiang Medical University,Xinxiang 453003,China; 2.Department of Endocrinology,the First Affiliated Hospital of Xinxiang Medical University,Xinxiang 453100,China)
关键词:
2型糖尿病;  非酒精性脂肪性肝病;  尿酸/高密度脂蛋白胆固醇比值;  性别;  影响因素;  预测价值
Keywords:
Type 2 diabetes;  Non-alcoholic fatty liver disease;  Uric acid to high-density lipoprotein cholesterol ratio;  Gender;  Influencing factor;  Predictive value
分类号:
R 587.2
DOI:
DOI:10.3969/j.issn.1000-7377.2025.03.007
文献标志码:
A
摘要:
目的:在2型糖尿病(T2DM)患者中探讨尿酸/高密度脂蛋白胆固醇比值(UHR)与非酒精性脂肪性肝病(NAFLD)的相关性,以及UHR对T2DM患者发生NAFLD的预测价值。方法:选取216例T2DM患者作为研究对象。检测血清肌酐(SCr)和血清尿酸(SUA)水平,并计算UHR。根据超声结果将患者分为T2DM合并NAFLD组(155例)和单纯T2DM组(61例)。根据UHR三份位数将患者分为U1组(UHR≤197.60)、U2组(197.60272.57),每组各72例,比较三组患者的NAFLD发生率。分析T2DM合并NAFLD的危险因素,评估UHR对 NAFLD 的预测价值。结果:T2DM合并NAFLD组BMI、舒张压(DBP)、白蛋白(ALB)、丙氨酸转氨酶(ALT)、天门冬氨基转移酶(AST)、空腹血糖(FPG)、总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、稳态模型胰岛素抵抗指数(HOMA-IR)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、空腹C肽(FC-P)、SUA、UHR高于单纯T2DM组,高密度脂蛋白胆固醇(HDL-C)、年龄、病程低于单纯T2DM组(均P<0.05)。U1组、U2组、U3 组患者NAFLD患病率呈显著增加趋势(P<0.05)。年龄、病程、BMI、ALT、FPG、LDL-C、UHR是T2DM患者合并NAFLD的影响因素(均P<0.05)。总人群和不同性别UHR对T2DM合并NAFLD均有一定的预测价值,且男性UHR的预测价值高于女性(均P<0.05)。结论:UHR是T2DM合并NAFLD的危险因素,对T2DM合并NAFLD具有良好的预测价值,且男性患者UHR的预测价值高于女性。
Abstract:
Objective:To investigate the association between uric acid/high-density lipoprotein cholesterol ratio(UHR)and non-alcoholic fatty liver disease(NAFLD)in patients with type 2 diabetes mellitus(T2DM),and the predictive value of UHR in the development of NAFLD in T2DM patients.Methods:A total of 216 T2DM patients were selected as the study objects.Serum creatinine(SCr)and serum uric acid(SUA)levels were measured,and UHR was calculated.The patients were divided into T2DM combined with NAFLD group(155 cases)and simple T2DM group(61 cases).The patients were divided into U1 group(UHR≤197.60),U2 group(197.60272.57)according to the UHR triplet,with 72 patients in each group.The incidence of NAFLD in three groups was compared.The risk factors of T2DM combined with NAFLD was analyzed,and the predictive value of UHR for NAFLD was evaluated.Results:BMI,DBP,ALB,ALT,AST,FPG,TC,TG,LDL-C,HOMA-IR,HbA1c,FINS,FC-P),SUA and UHR in T2DM combined with NAFLD group were higher than those in simple T2DM group,but HDL-C,age and disease course were lower than those in simple T2DM group(all P<0.05).The prevalence of NAFLD in U1,U2 and U3 groups was significantly increased(P<0.05).Age,course of disease,BMI,ALT,FPG,LDL-C and UHR were the influencing factors of T2DM patients combined with NAFLD(all P<0.05).Both the general population and different gender UHR had certain predictive value for T2DM combined with NAFLD,and the predictive value of male UHR was higher than that of female(all P<0.05).Conclusion:UHR is a risk factor for T2DM combined with NAFLD,and has good predictive value,and the predictive value of UHR in male patients is higher than that in female patients.

参考文献/References:

[1] 延华,柴春艳,张丹,等.基于JNK信号通路探讨自噬、胰岛素抵抗在非酒精性脂肪性肝病中的发病机制[J].陕西医学杂志,2023,52(11):1506-1510.
[2] 刘艳如,温晓华,高冕,等.非肥胖人群血浆致动脉硬化指数与非酒精性脂肪性肝病的相关性[J].临床误诊误治,2021,34(10):94-98.
[3] 陈慧婷,周永健.非肥胖型非酒精性脂肪性肝病的诊治对策[J].中华肝脏病杂志,2020,28(3):203-207.
[4] 李彦彦,赵丽,邓霞,等.2型糖尿病患者心脏代谢指数与非酒精性脂肪性肝病的关系研究[J].中国全科医学,2021,24(15):1883-1888.
[5] YOUNOSSI Z M.Non-alcoholic fatty liver disease:A global public health perspective[J].J Hepatol,2019,70(3):531-544.
[6] 韩孟冉,张晨钰,杜岑,等.血小板/白细胞比值与2型糖尿病合并非酒精性脂肪性肝病患者肝纤维化进展的相关性[J].中国医科大学学报,2022,51(6):492-496,507.
[7] DOYCHEVA I,ZHANG T,AMJAD W,et al.Diabetes and hepatocellular carcinoma:Incidence trends and impact of liver disease etiology[J].J Clin Exp Hepatol,2020,10(4):296-303.
[8] KOSEKLI M A,KURTKULAGII O,KAHVECI G,et al.The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease:The abund study[J].Rev Assoc Med Bras(1992),2021,67(4):549-554.
[9] KURTKULAGI O,TEL B,KAHVECI G,et al.Hashimoto's thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio[J].Rom J Intern Med,2021,59(4):403-408.
[10] PARK B,JUNG D H,LEE Y J.Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans[J].Biomedicines,2022,10(6):1422.
[11] 尤玉青,李伟,周东浩.血尿酸/高密度脂蛋白胆固醇比值与糖尿病肾脏疾病的相关性研究[J].中国糖尿病杂志,2021,29(10):749-753.
[12] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J].国际内分泌代谢杂志,2021,41(5):482-548.
[13] 张宇新,张永红.非酒精性脂肪肝合并2型糖尿病的临床特征分析[J].包头医学院学报,2024,40(1):71-76.
[14] TANASE D M,GOSAV E M,COSTEA C F,et al.The Intricate relationship between type 2 diabetes mellitus(T2DM),insulin resistance(IR),and nonalcoholic fatty liver disease(NAFLD)[J].J Diabetes Res,2020,2020:3920196.
[15] KANG S H,LEE H W,YOO J J,et al.KASL clinical practice guidelines:Management of nonalcoholic fatty liver disease[J].Clin Mol Hepatol,2021,27(3):363-401.
[16] 林先佳,王小锋,张媛媛,等.基于网络药理学和分子对接探讨肝脂平治疗非酒精性脂肪性肝病作用机制[J].陕西中医,2023,44(4):524-529.
[17] 单蕊,陈燕,姚政.肠道菌群与非酒精性脂肪肝病相关性研究进展[J].中国微生态学杂志,2019,31(7):841-843.
[18] 阎利萍,左吉卉,吴明江,等.脂肪酸代谢与非酒精性脂肪肝疾病关系的研究进展[J].中国医药科学,2020,10(20):35-39.
[19] 杨小雄,杨帆,魏小果.非酒精性脂肪性肝病发病机制的研究进展[J].中国医药,2023,18(12):1911-1915.
[20] 刘宇婷,郑之然,刘雨露,等.运动干预T2DM肝脏脂代谢作用研究进展[J].生命的化学,2022,42(6):1152-1160.
[21] ZHOU X,XU J.Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus[J].J Diabetes Investig,2024,15(1):113-120.
[22] CUI Y,QU Z,HU W,et al.Relationship between uric acid to high density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease in nonoverweight/obese patients with type 2 diabetes[J].Int J Endocrinol,2023,2023:2513175.
[23] 蔡金玲,董其娟,范慧洁,等.不同性别2型糖尿病患者腹部脂肪与糖尿病视网膜病变的相关性[J].河南医学研究,2021,30(31):5765-5768.
[24] 龚凤英,胡雯婧.脂肪组织:一个具有高度异质性和可塑性的内分泌和免疫器官[J].中华糖尿病杂志,2022,14(12):1469-1474.
[25] LONARDO A,NASCIMBENI F,BALLESTRI S,et al.Sex differences in nonalcoholic fatty liver disease:State of the art and identification of research gaps[J].Hepatology,2019,70(4):1457-1469.
[26] 沈怡蓉,刘若双,喻夏雯,等.2型糖尿病患者尿酸/高密度脂蛋白胆固醇比值与内脏脂肪面积的相关性研究[J].中华糖尿病杂志,2022,14(9):954-960.

相似文献/References:

[1]李艳艳,贾 伟△.24h动态心电图在2型糖尿病合并冠心病患者心律诊断中的价值分析[J].陕西医学杂志,2019,(1):61.
[2]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
　GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(3):77.
[3]刘毅龙,陈鹏宇,雷 江,等.SGLT2抑制剂在2型糖尿病合并心血管疾病治疗中的应用研究进展[J].陕西医学杂志,2019,(3):407.
[4]姚爱红.利拉鲁肽治疗2型糖尿病效果及对患者血脂、颈动脉内膜中层厚度的影响[J].陕西医学杂志,2019,(4):518.
　YAO Aihong..Effect of liraglutide on type 2 diabetes mellitus in patients with blood lipids and carotid intimamedia thickness[J].,2019,(3):518.
[5]李忆琴,吴礼凤,余晓君,等.中年2型糖尿病患者病程和HbA1c水平与认知功能相关性研究*[J].陕西医学杂志,2019,(6):722.
[6]徐 琳,贾睿博△,宋民喜,等.颗粒蛋白前体与糖尿病肾病关系探讨*[J].陕西医学杂志,2019,(8):1024.
[7]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
　WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(3):1032.
[8]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
　WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(3):1163.
[9]贾睿博,徐 琳△.2型糖尿病患者下肢血管病变相关危险因素调查研究[J].陕西医学杂志,2019,(11):1567.
[10]郭建强,赵俊宏,张分队,等.2型糖尿病视网膜病变患者血清HbA1c、CysC检测及临床意义*[J].陕西医学杂志,2020,49(5):619.
　GUO Jianqiang,ZHAO Junhong,ZHANG Fendui,et al.Changes of serum HbA1c and CysC in patients with type 2 diabetic retinopathy and their clinical significance[J].,2020,49(3):619.
[11]安 欣,刘鲁豫,王成凯.2型糖尿病患者尿微量白蛋白肌酐比值与非酒精性脂肪性肝病相关性分析[J].陕西医学杂志,2021,50(11):1416.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.023]
[12]李 辉,安盟盟,张 会,等.司美格鲁肽联合非诺贝特治疗2型糖尿病合并非酒精性脂肪性肝病疗效及安全性观察[J].陕西医学杂志,2025,54(3):378.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.018]
　LI Hui,AN Mengmeng,ZHANG Hui,et al.Efficacy and safety of semaglutide combined with fenofibrate in treatment of T2DM complicated with NAFLD[J].,2025,54(3):378.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.018]

备注/Memo

备注/Memo:
[基金项目]河南省医学科技攻关计划联合共建项目(LHGJ20220593)
更新日期/Last Update: 2025-03-05